RxDoctor Payments Data

Matthew Seidel, MD

Orthopaedic Surgery · Phoenix, AZNPI 1376523399

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (56.7%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Onkos Surgical, Inc. at 38.9% of the total. Among orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$397,174in general payments, 2019–2025

Across 206 payments — averaging $1928.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Onkos Surgical, Inc.$155K
  • Microport Orthopedics Inc$152K
  • Linkbio Corp$51K
  • Stryker$27K
  • Daiichi Sankyo Inc.$9K
  • Bone Support Inc.$3K
  • plus $607 from 9 others

What the payments were for

  • Royalty or licence$225,11957%
  • Consulting fees$82,78521%
  • Speaking & faculty fees$50,74513%
  • Travel & lodging$31,6138%
  • Food & beverage$6,9122%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$397,174 in reported general payments places this provider in the 95th percentile of 377 orthopaedic surgery providers in Arizona.

See all orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$182,164
Medicare patients
332
Services billed
4,337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen41$401
Gabapentin22$400
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$379
Oxycodone Hcl44$207
Cephalexin25$154
Methylprednisolone24$130
Tramadol Hcl20$39

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →